Outlines CCSA’s activities in fiscal year 2022–2023 and provides the auditor’s report. Highlights how, together with our partners, we offered people in Canada the latest insights and knowledge on the effects of substance use.
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
Reviews research about the relationship between cannabis use and a number of mental health conditions.
Wednesday 4 November 13:00-14:30pm EST.
Presents the latest clinical evidence on cannabis use and impaired driving among Canadians.
The Leadership Team at CCSA is responsible for ensuring CCSA achieves its strategic goals. The team develops strategic directions that align with the mandate of the organization and its core functions.
Describes the availability of take-home naloxone programs in Canada and the steps required to make naloxone available without a prescription.
Reviews research about the relationship between cannabis use and cognitive functioning.
Reviews research about the effects of smoking cannabis on the cardiovascular and respiratory systems (heart and lungs).
Summarizes possible drug-related harms that occurred at Canadian music festivals between June and August 2014. The bulletin provides an overview of the number of attendees and the suspected number of drug-related deaths and illnesses.
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
Illustrates what people should know before consuming edible cannabis, including reading the label to understand how much THC a product contains, and the importance of staring low — no more than 2.5 mg of THC — and going slow.
